TM
Thermo Fisher Scientific
TMO · NYSE
$606.17 +0.52% (+$3.15)
1M +0.11%
Market Cap $225.3B
P/E Ratio 32.28x
Div. Yield 0.30%
ROE 13.35%
Bulios Fair Price
$474.87
21.7% downside
Trenutna cena
$606.17
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TMO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
25 /100
Expensive P/E 32.28x
EV/EBITDA 24.12x
P/S 4.86x
Growth
24 /100
Declining EPS growth 0.19%
Rev. growth 0.27%
FCF growth 3.07%
Profitability
83 /100
Strong Gross margin 40.37%
Net margin 15.06%
Op. margin 17.69%
Quality
49 /100
Average ROIC 7.45%
ROE 13.35%
ROA 6.17%
Debt
54 /100
Moderate Debt/Equity 0.81x
Current ratio 1.55x
Int. coverage 5.88x
Stability
100 /100
Stable Beta 0.85x
Rev. volatility 4.25%
EPS volatility 11.30%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TMO
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Marc N. Casper
Employees
125,000
Headquarters
Waltham
Prihajajoči dogodki
15 SEP.
Ex-Dividend
Ex-dividend date
15 OKT.
Dividend Payment
Datum plačila
28 OKT.
Earnings
Upcoming earnings report